Avalo Therapeutics (AVTX) Other Operating Expenses (2017 - 2024)
Avalo Therapeutics (AVTX) posted Other Operating Expenses of $87000.0 for Q4 2024, up 112.18% on a QoQ basis from -$714000.0 in Q3 2024, and down 97.64% year-over-year from $3.7 million in Q1 2024.
Avalo Therapeutics (AVTX) Other Operating Expenses (2017 - 2024) Analysis & Trends
Avalo Therapeutics' Other Operating Expenses history runs 7 years deep, the most recent figure standing at $87000.0 for Q4 2024.
- Quarterly Other Operating Expenses fell 97.64% year-over-year to $87000.0 in Q4 2024, while the trailing twelve-month figure through Sep 2025 was $87000.0 (down 99.72% YoY) and the FY2024 annual result came in at $27.3 million, up 425.43% from the prior year.
- Other Operating Expenses was $87000.0 for Q4 2024 at Avalo Therapeutics, up from -$714000.0 in the prior quarter.
- Across five years, Other Operating Expenses topped out at $27.5 million in Q1 2024 and bottomed at -$714000.0 in Q3 2024.
- A 4-year average of $4.0 million and a median of $655500.0 in 2021 frame the typical range for Other Operating Expenses.
- Peak annual rise in Other Operating Expenses reached 4883.3% in 2024, while the deepest fall reached 389.07% in 2024.
- Avalo Therapeutics' Other Operating Expenses stood at $691000.0 in 2021, then retreated by 10.27% to $620000.0 in 2022, then soared by 494.52% to $3.7 million in 2023, then slumped by 97.64% to $87000.0 in 2024.
- Business Quant data shows AVTX's Other Operating Expenses at $87000.0 in Q4 2024, -$714000.0 in Q3 2024, and $446000.0 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Avalo Therapeutics | 1.04 Mn | 1.04 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 87,000.00 |
| Sep 30, 2024 | -714,000.00 |
| Jun 30, 2024 | 446,000.00 |
| Mar 31, 2024 | 27.46 Mn |
| Dec 31, 2023 | 3.69 Mn |
| Sep 30, 2023 | 247,000.00 |
| Jun 30, 2023 | 708,000.00 |
| Mar 31, 2023 | 551,000.00 |
| Dec 31, 2022 | 620,000.00 |
| Sep 30, 2022 | 528,000.00 |
| Jun 30, 2022 | 1.57 Mn |
| Mar 31, 2022 | 758,000.00 |
| Dec 31, 2021 | 691,000.00 |
| Sep 30, 2021 | 1.34 Mn |
| Jun 30, 2021 | 511,000.00 |
| Mar 31, 2021 | 25.71 Mn |
| Dec 31, 2019 | 1.00 |
| Jun 30, 2019 | 1.28 Mn |
| Mar 31, 2019 | -20,940.00 |
| Dec 31, 2018 | 471,773.00 |